FDA Grants Approval for Tretinoin ANDA214590 by Alembic
The FDA has granted approval for Alembic's Abbreviated New Drug Application (ANDA) for Tretinoin.
Asset / Drug
Drug and asset intelligence for Tretinoin with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.